Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
biote (BTMD)
NASDAQ:BTMD
biote (BTMD) Stock Price & Analysis
42 Followers
BTMD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.65 - $8.22
Previous Close$5.95
Volume326.00
Average Volume (3M)116.70K
Market Cap
$369.12M
Enterprise Value$387.84M
Total Cash (Recent Filing)$89.00M
Total Debt (Recent Filing)$114.87M
Price to Earnings (P/E)105.3
Beta0.04
Next Earnings
Aug 07, 2024EPS Estimate
$0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.06
Shares Outstanding62,036,479
10 Day Avg. Volume109,105
30 Day Avg. Volume116,705
Standard Deviation0.17
R-Squared0.07
Alpha-0.00747
Financial Highlights & Ratios
Price to Book (P/B)-10.85
Price to Sales (P/S)0.97
Price to Cash Flow (P/CF)13.40
P/FCF Ratio15.70
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.09
Enterprise Value/Gross Profit3.04
Enterprise Value/Ebitda105.82
Forecast
1Y Price Target
$8.56Price Target Upside43.87% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
biote News
PremiumCompany Announcements
Biote Settles Litigation and Repurchases Shares from Founder
PremiumCompany Announcements
Biote Corp. Releases March 2024 Investor PresentationBulls Say, Bears Say
Bulls Say
Market OpportunityHormone deficiency affecting 200 million Americans with approximately 80% untreated presents a substantial opportunity for BTMD.
Product LaunchOngoing work to improve the sales force productivity could start to bear fruit combined with the BioteRX launch.
Sales GrowthManagement sounds confident about sales growth accelerating in the back half.
Bears Say
Distribution ChallengesThe stock may face headwinds as the company goes through a transition year with notable disruptions with a key distributor.
Financial PerformanceAnalysts have lowered their financial estimates, signaling potential concerns about the company's near-term performance in the nutraceutical sector.
Revenue And EarningsProjected revenue and EBITDA figures for the fiscal year show a significant step down, which could impact investor confidence.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BTMD FAQ
What was biote’s price range in the past 12 months?
biote lowest stock price was $3.65 and its highest was $8.22 in the past 12 months.
What is biote’s market cap?
Currently, no data Available
When is biote’s upcoming earnings report date?
biote’s upcoming earnings report date is Aug 07, 2024 which is in 84 days.
How were biote’s earnings last quarter?
biote released its earnings results on May 07, 2024. The company reported -$0.06 earnings per share for the quarter, missing the consensus estimate of $0.05 by -$0.11.
Is biote overvalued?
According to Wall Street analysts biote’s price is currently Undervalued.
Does biote pay dividends?
biote does not currently pay dividends.
What is biote’s EPS estimate?
biote’s EPS estimate is $0.07.
How many shares outstanding does biote have?
biote has 30,320,599 shares outstanding.
What happened to biote’s price movement after its last earnings report?
biote reported an EPS of -$0.06 in its last earnings report, missing expectations of $0.05. Following the earnings report the stock price went up 5.199%.
Which hedge fund is a major shareholder of biote?
Among the largest hedge funds holding biote’s share is Bandera Partners. It holds biote’s shares valued at 9M.
---
biote Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$8.56 (43.87% Upside)
$8.56 (43.87% Upside)
Blogger Sentiment
Bullish
BTMD Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 127.4K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
0.67%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
34.39%
Trailing 12-Months
Company Description
biote
Haymaker Acquisition Corp III is a blank check company.
---
BTMD Earnings Call
Q1 2024
0:00 / 0:00
---
BTMD Stock 12 Month Forecast
Average Price Target
$8.56
▲(43.87% Upside)
Technical Analysis
Best Analysts Covering BTMD
1 Year
1 Year Success Rate
3/4 ratings generated profit
1 Year Average Return
+39.13%
reiterated a buy rating 2 months ago
Copying George Kelly's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +39.13% per trade.
---